Ruihua Dong

机构：Capital Medical University, Beijing Friendship Hospital, Shanghai Cell Therapy Research Institute · ORCID：0000-0003-3463-5023

发表论文 41 篇 · 总被引 462 次 · h-index 12

代表论文

• Safety, tolerability, and pharmacokinetics of oral baicalein tablets in healthy Chinese subjects: A single‐center, randomized, double‐blind, placebo‐controlled multiple‐ascending‐dose study (2021 · Clinical and Translational Science · 被引 80)
• Safety, tolerability, pharmacokinetics, and food effect of baicalein tablets in healthy Chinese subjects: A single-center, randomized, double-blind, placebo-controlled, single-dose phase I study (2021 · Journal of Ethnopharmacology · 被引 60)
• Microplastics release from infant feeding bottles and milk storage bags (2024 · Food Control · 被引 31)
• Multi-armed antibiotics for Gram-positive bacteria (2023 · Cell Host & Microbe · 被引 20)
• Quercetin intervention mitigates small intestinal damage and immunologic derangement induced by polystyrene nanoplastics: Insights from multi-omics analysis in mice (2024 · Environmental Pollution · 被引 18)
• ZSP1601, a novel pan-phosphodiesterase inhibitor for the treatment of NAFLD, A randomized, placebo-controlled phase Ib/IIa trial (2023 · Nature Communications · 被引 17)